Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycine and D-cycloserine added to Clozapine in Schizophrenia
NCT00000372Phase 3Withdrawn
- Sponsor
- Massachusetts General Hospital
- Start
- Mar 1998
- Primary completion
- Nov 2005
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of glycine, d-cycloserine in schizophrenia, sponsored by Massachusetts General Hospital. Planned start Mar 1998; status: withdrawn.
02
Drugs
glycined-cycloserine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00000372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000372.